Literature DB >> 25721658

Norovirus genotype diversity associated with gastroenteritis outbreaks in aged-care facilities.

L D Bruggink1, N L Dunbar1, J A Marshall1.   

Abstract

Noroviruses are a major cause of gastroenteritis. Vaccine strategies against norovirus are currently under consideration but depend on a detailed knowledge of the capsid genotypes. This study examined the incidence of norovirus outbreaks in residential aged-care facilities in Victoria, Australia over one year (2013) and documented the (capsid) norovirus genotypes associated with these outbreaks. It was found that 65·0% of 206 outbreaks tested were associated with norovirus infection, thereby showing norovirus to be the major cause of viral gastroenteritis in residential aged-care facilities. Fifteen capsid (open reading frame 2) genotypes were identified as follows: GI.2 (0·9%), GI.3 (1·8%), GI.4 (3·7%), GI.6 (0·9%), GI.7 (0·9%), GI.8 (0·9%), GII.1 (0·9%), GII.2 (0·9%), GII.3 (1·8%), GII.4 (2009-like) (0·9%), GII.4 (2012) (48·6%), GII.4 (2012-like) (16·5%), GII.4 (unknown) (9·2%), GII.5 (2·8%), GII.6 (0·9%), GII.7 (0·9%), GII.13 (6·4%) and an as yet unclassified GII genotype (0·9%). Although GII.4 was the most common norovirus capsid genotype detected, the great diversity of norovirus genotypes in the elderly indicates vaccination strategies for this demographic are not straightforward.

Entities:  

Keywords:  Aged care; genotypes; norovirus; outbreaks; vaccine strategies

Mesh:

Substances:

Year:  2015        PMID: 25721658      PMCID: PMC9151030          DOI: 10.1017/S095026881500031X

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  9 in total

1.  Molecular and epidemiological features of GIIb norovirus outbreaks in Victoria, Australia, 2002-2005.

Authors:  L D Bruggink; J A Marshall
Journal:  J Med Virol       Date:  2009-09       Impact factor: 2.327

2.  Norovirus epidemics are linked to two distinct sets of controlling factors.

Authors:  Leesa D Bruggink; John A Marshall
Journal:  Int J Infect Dis       Date:  2008-10-09       Impact factor: 3.623

3.  Food-borne viruses in Europe network report: the norovirus GII.4 2006b (for US named Minerva-like, for Japan Kobe034-like, for UK V6) variant now dominant in early seasonal surveillance.

Authors:  J Siebenga; Annelies Kroneman; H Vennema; E Duizer; M Koopmans
Journal:  Euro Surveill       Date:  2008-01-10

4.  An automated genotyping tool for enteroviruses and noroviruses.

Authors:  A Kroneman; H Vennema; K Deforche; H v d Avoort; S Peñaranda; M S Oberste; J Vinjé; M Koopmans
Journal:  J Clin Virol       Date:  2011-04-21       Impact factor: 3.168

5.  Molecular and epidemiological features of gastroenteritis outbreaks involving genogroup I norovirus in Victoria, Australia, 2002-2010.

Authors:  Leesa D Bruggink; Osunneye Oluwatoyin; Rizmina Sameer; Kristie J Witlox; John A Marshall
Journal:  J Med Virol       Date:  2012-09       Impact factor: 2.327

6.  The potential economic value of a human norovirus vaccine for the United States.

Authors:  Sarah M Bartsch; Benjamin A Lopman; Aron J Hall; Umesh D Parashar; Bruce Y Lee
Journal:  Vaccine       Date:  2012-09-28       Impact factor: 3.641

7.  Detection of genogroup IV noroviruses in environmental and clinical samples and partial sequencing through rapid amplification of cDNA ends.

Authors:  G La Rosa; M Pourshaban; M Iaconelli; M Muscillo
Journal:  Arch Virol       Date:  2008-11-06       Impact factor: 2.574

8.  Surveillance for outbreaks of gastroenteritis in elderly long-term care facilities in France, November 2010 to May 2012.

Authors:  A S Barret; N Jourdan-da Silva; K Ambert-Balay; G Delmas; A Bone; J M Thiolet; V Vaillant
Journal:  Euro Surveill       Date:  2014-07-24

9.  Norovirus disease in the United States.

Authors:  Aron J Hall; Ben A Lopman; Daniel C Payne; Manish M Patel; Paul A Gastañaduy; Jan Vinjé; Umesh D Parashar
Journal:  Emerg Infect Dis       Date:  2013-08       Impact factor: 6.883

  9 in total
  4 in total

1.  Structural Adaptations of Norovirus GII.17/13/21 Lineage through Two Distinct Evolutionary Paths.

Authors:  Ying Qian; Mohan Song; Ming Tan; Yutao Chen; Xuemei Li; Xi Jiang; Ming Xia; Jarek Meller; Zihe Rao
Journal:  J Virol       Date:  2018-12-10       Impact factor: 5.103

2.  A Unique Human Norovirus Lineage with a Distinct HBGA Binding Interface.

Authors:  Wu Liu; Yutao Chen; Xi Jiang; Ming Xia; Yang Yang; Ming Tan; Xuemei Li; Zihe Rao
Journal:  PLoS Pathog       Date:  2015-07-06       Impact factor: 6.823

3.  Serum Immunoglobulin A Cross-Strain Blockade of Human Noroviruses.

Authors:  Lisa C Lindesmith; Martina Beltramello; Jesica Swanstrom; Taylor A Jones; Davide Corti; Antonio Lanzavecchia; Ralph S Baric
Journal:  Open Forum Infect Dis       Date:  2015-07-01       Impact factor: 3.835

4.  Virological and Epidemiological Features of Norovirus Infections in Brazil, 2017-2018.

Authors:  Sylvia Kahwage Sarmento; Juliana da Silva Ribeiro de Andrade; Marize Pereira Miagostovich; Tulio Machado Fumian
Journal:  Viruses       Date:  2021-08-30       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.